JAPANESE FOUNDATION FOR CANCER RESEARCH
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1908-04-02
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.jfcr.or.jp
A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer
Phase 3
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- Japanese Foundation for Cancer Research
- Target Recruit Count
- 280
- Registration Number
- NCT04732598
- Locations
- 🇯🇵
Cancer Institute Hospital of JFCR, Tokyo, Japan
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
Phase 1
Completed
- Conditions
- Esophageal Cancer
- First Posted Date
- 2007-11-20
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Japanese Foundation for Cancer Research
- Target Recruit Count
- 6
- Registration Number
- NCT00561275
- Locations
- 🇯🇵
Takuya Takayama M.D.Ph.D, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath